Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Huntington Chorea”

Showing 20 of 0 results

Very early researchEnded earlyNCT03810898
What this trial is testing

IMagemHTT: FIH Evaluation of Novel Mutant Huntingtin PET Radioligands [¹¹C]CHDI-00485180-R and [¹¹C]CHDI-00485626

Who this might be right for
Huntington Disease
CHDI Foundation, Inc. 24
Testing effectiveness (Phase 2)Ended earlyNCT04617860
What this trial is testing

Open-label Extension Study to Evaluate the Safety and Tolerability of WVE-120102 in Patients With Huntington's Disease

Who this might be right for
Huntington Disease
Wave Life Sciences USA, Inc. 36
Testing effectiveness (Phase 2)Active Not RecruitingNCT07339514
What this trial is testing

A Phase I Clinical Study of ER2001 Injection for the Treatment of Early Manifest Huntington's Disease.

Who this might be right for
Huntington Disease
ExoRNA Bioscience 27
Testing effectiveness (Phase 2)Study completedNCT02197130
What this trial is testing

Randomized, Placebo Controlled Study Of The Efficacy And Safety Of PF-02545920 In Subjects With Huntington's Disease

Who this might be right for
Huntington's Disease
Pfizer 272
Testing effectiveness (Phase 2)Study completedNCT01411150
What this trial is testing

Premanifest Huntington's Disease: Creatine Safety & Tolerability Extension Study

Who this might be right for
Huntington's Disease
Massachusetts General Hospital 38
Not applicableStudy completedNCT04917133
What this trial is testing

Adapted Physical Activity Effect on Abilities and Quality of Life of Huntington Patients and Relatives During Rehab Stay

Who this might be right for
Huntington Disease
Assistance Publique - Hôpitaux de Paris 32
Testing effectiveness (Phase 2)Ended earlyNCT05111249
What this trial is testing

A Dose Range Finding Study With Open-Label Extension to Evaluate the Safety of Oral LMI070/Branaplam in Early Manifest Huntington's Disease

Who this might be right for
Early Manifest Huntington Disease
Novartis Pharmaceuticals 26
Not applicableStudy completedNCT00539747
What this trial is testing

Making Sense of a Positive Genetic Test Result for Huntington Disease

Who this might be right for
Huntington Disease
National Human Genome Research Institute (NHGRI) 50
Testing effectiveness (Phase 2)Study completedNCT03575676
What this trial is testing

Efficacy and Safety of SOM3355 in Huntington's Disease Chorea

Who this might be right for
Huntington's Chorea
SOM Innovation Biotech SA 32
Not applicableLooking for participantsNCT06843252
What this trial is testing

Home-based TDCS (Transcranial Direct Current Stimulation) for Cognitive and Behavioral Symptoms in Huntington's Disease

Who this might be right for
Huntington Disease
The University of Texas Health Science Center at San Antonio 16
Large-scale testing (Phase 3)Study completedNCT04102579
What this trial is testing

Efficacy, Safety, and Tolerability of Valbenazine for the Treatment of Chorea Associated With Huntington Disease

Who this might be right for
Chorea, Huntington
Neurocrine Biosciences 128
Testing effectiveness (Phase 2)Study completedNCT02215616
What this trial is testing

A Clinical Study in Participants With Huntington's Disease (HD) to Assess Efficacy and Safety of Three Oral Doses of Laquinimod

Who this might be right for
Huntington's Disease
Teva Branded Pharmaceutical Products R&D, Inc. 352
Not applicableUnknownNCT01554033
What this trial is testing

Study of Huntington Patients in Connection With European Huntington's Disease Network (EHDN)

Who this might be right for
Huntington Disease
Seoul National University Hospital 200
Early research (Phase 1)Study completedNCT00824590
What this trial is testing

A Phase 1, Non-Randomized, Open-Label, Single-Dose Study To Evaluate The Pharmacokinetics, Safety, And Tolerability Of Dimebon [PF 01913539] In Subjects With Severely-Impaired And Normal Renal Function

Who this might be right for
Alzheimer's DiseaseHuntington's Disease
Pfizer 20
Early research (Phase 1)UnknownNCT03713892
What this trial is testing

CKD-504 in SAD and MAD in Healthy Korean and Caucasian Adult Male and Female Subjects

Who this might be right for
Huntington Disease
Chong Kun Dang Pharmaceutical 88
Early research (Phase 1)Study completedNCT01521832
What this trial is testing

Escalating Dose Study in Healthy Volunteers With SEN0014196

Who this might be right for
Huntington's Disease
Siena Biotech S.p.A. 88
Large-scale testing (Phase 3)Study completedNCT01795859
What this trial is testing

First Time Use of SD-809 in Huntington Disease

Who this might be right for
Chorea
Teva Branded Pharmaceutical Products R&D, Inc. 90
Not applicableLooking for participantsNCT01574053
What this trial is testing

Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort

Who this might be right for
Huntington's Disease
CHDI Foundation, Inc. 35,000
Very early researchStudy completedNCT07344519
What this trial is testing

The Safety and Tolerability Study With ER2001 Intravenous Injection Repetitive Treatment in Adults With Early Manifest Huntington's Disease.

Who this might be right for
Huntington Disease
ExoRNA Bioscience 8
Large-scale testing (Phase 3)Ended earlyNCT05655520
What this trial is testing

Evaluate the Safety and Tolerability of SAGE-718 in Participants With Huntington's Disease

Who this might be right for
Huntington's Disease
Supernus Pharmaceuticals, Inc. 153
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation